Home / Aprepitant / Australia
AU ATC A04AD12 · updated 2 Nov 2026
Aprepitant shortage in Australia
Is there an Aprepitant shortage in Australia?
Yes. As of 2 Nov 2026, 2 Aprepitant products are reported short in Australia, the first since 13 Feb 2026. The company estimate for the return is 16 Apr 2027 (latest 31 Dec 2028). Main reason: not stated.
Also short in United States, Canada, Germany, France, Italy, Spain, Ireland, Austria, Czechia, Norway, Sweden. All countries.
Affected products in Australia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AU | APREPITANT ARX aprepitant 165 mg capsule blister pack discontinuation | 13 Feb 2026 | 16 Apr 2027 | Not stated | |
| AU | APREPITANT LUPIN aprepitant 165 mg capsule blister pack discontinuation | 2 Jul 2026 | 31 Dec 2028 | Not stated |
Source
Therapeutic Goods Administration (TGA), Medicine Shortage Reports Database. Official list. National shortages of reportable medicines, current and anticipated within six months; one row per product.